Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)

cell products

cell products, Total:277 items.

The international standard classification for "cell products" includes: Biology. Botany. Zoology , Protection against dangerous goods , Microbiology , Pesticides and other agrochemicals , Other organic chemicals , Medical Sciences and health care facilities in general , Laboratory medicine , Transfusion, infusion and injection equipment , Medical materials .

The Chinese standard classification for "cell products" includes: Basic Subject in general , Basic standards and general methods , Cereal crop and forage crop in general , Other cash crops , Marking, packaging, transport and storage in general , Food sanitation , Pesticide management and application method , Technical Management , General organic chemicals , Biological agent and blood products , Sanitation in general , Medical laboratory equipment , Raw pharmaceutical material processing machinery and equipment , Marking, packaing, transport and storage , Medical apparatus and devices in general .


Professional Standard - Education

Professional Standard - Agriculture

  • 1317药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Stimulating Factor
  • 1145兽药质量标准2017年版 Biological Products Volume II Veterinary Drug Quality Standards Inactivated Cysticercus Porcine Cell Vaccine (CC-97 Cell Line) Instructions
  • 262药典 四部-2015 3400 biological assay 3426 human erythrocyte antibody assay
  • 1021药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drugs Recombinant Human Granulocyte Macrophage Stimulating Factor
  • 327药典 三部-2020 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
  • 142药典 三部-2015 Monograph II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
  • 163兽药典 三部-2015 Appendix Table of Contents Specific Biological Raw Materials Animal 3502 Cell Standards for Production
  • 24药典 三部-2015 General rules for biological products Preparation and testing procedures for animal cell substrates used in the production and testing of biological products
  • 9药典 三部-2010 General headings Preparation and verification procedures of animal cell matrix for production and verification of biological products
  • 1318药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Macrophage Stimulating Factor
  • 916兽药质量标准2017年版 Biological Products Volume 1 Veterinary Drug Quality Standard Inactivated Cysticercus Porcine Cell Oil Emulsion Vaccine (CC-97 Cell Line)
  • GB/T 15193.6-2003 Mammalian bone marrow cell chromosome aberration test
  • 19药典 三部-2020 General rules for biological products Preparation and quality control of animal cell substrates for production and testing of biological products
  • 306药典 三部-2020 Bioassay 3426 Human Erythrocyte Antibody Assay
  • 150药典 三部-2020 Monograph Ⅱ Therapeutic topical human granulocyte macrophage stimulating factor gel
  • 337药典 三部-2020 Biological Activity-Potency Assay 3526 Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
  • 284药典 四部-2020 3500 Biological Activity-Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
  • 274药典 四部-2020 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
  • 583药典 化学药和生物制品卷-2010 Chapter VIII Drugs for Blood System Section 1 Drugs for Raising Blood Cells 2. Drugs for Raising Leukocytes Recombinant Human Granulocyte Stimulating Factor
  • 308药典 三部-2015 Biological Activity - Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay General Rules 135
  • 255药典 四部-2020 3400 biological assay 3426 human erythrocyte antibody assay
  • 584药典 化学药和生物制品卷-2010 Chapter VIII Drugs for Blood System Section 1 Drugs for Raising Blood Cells 2. Drugs for Raising Leukocytes Recombinant Human Granulocyte Macrophage Stimulating Factor
  • 289药典 四部-2015 3500 Biological Activity-Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
  • 247药典 三部-2010 Appendix Ⅹ XF Determination of Biological Activity of Recombinant Human Granulocyte Macrophage Stimulating Factor
  • 279药典 四部-2015 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
  • 水产品质量安全检验手册 3.8.1.0-2005 Chapter 3 Inspection of microorganisms in aquatic products Section 8 Inspection of Listeria monocytogenes 1. Inspection of Listeria monocytogenes (GBT 4789.30-2003)
  • 1320药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Bovine Basic Fibroblast Growth Factor
  • 298药典 三部-2015 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test) General 129
  • 149药典 三部-2020 Monograph II Therapeutic Human Granulocyte Macrophage Stimulating Factor for Injection
  • 水产品质量安全检验手册 3.8.2.0-2005 Chapter 3 Inspection of microorganisms in aquatic products Section 8 Inspection of Listeria monocytogenes 2. Inspection of Listeria monocytogenes (SN 0184-1993)
  • 1324药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interleukin-11

Group Standards of the People's Republic of China

  • T/CALAS 86-2020 Laboratory animal-PCR method for detection of murine cytomegalovirus
  • T/CGCPU 009-2020 Control requirements for the preparation process of immune cell products
  • T/GDC 213-2023 Cell Strainers
  • T/SHSYCXH 8-2022 Test method of human Natural Killer cells and Natural Killer T cells from peripheral blood-Flow cytometry
  • T/QMHIPA 004-2022 Specification of Release Testing for Stem Cell-based Medicinal Products of Cell Preparation Center
  • T/CECCEDA 003.2-2023 Technical requirement of single-use materials in CAR-T production Part 2: Cell sap culture tank
  • T/SDHCST 001-2022 Technical Specification for Artificially Induced Pluripotent Stem Cells to Differentiate into Neural Cells
  • T/CRHA 001-2021 Human mesenchymal stem cell derived small extracellular vesicles
  • T/CRHA 008-2022 Specification for mononuclear cell resource storage in healthy blood donors Part 5:Quality evaluation and release of mononuclear cell products
  • T/LNSI 004-2023 Human cytokine induced killer cell
  • T/SDHCST 001-2023 General Principles on the Non-Clinical Studies of the Cell Therapy Medical Products
  • T/SDHCST 003-2023 Pre-dose Quality Testing of Test Substances in Non-clinical Studies of the Cell Therapy Medical Products
  • T/CASME 535-2023 Cell culture microtiter plate
  • T/CSCB 0004-2021 Human hematopoietic stem/progenitor cell
  • T/CSCB 0003-2021 Human mesenchymal stem cell
  • T/CRHA 002-2021 Human pluripotent stem cell derived small extracellular vesicles
  • T/CSCB 0008-2021 Primary human hepatocyte
  • T/CSCB 0005-2021 Human induced pluripotent stem cell
  • T/CGCPU 011-2020 Quality Control Requirements for Immune Cell Products
  • T/SHQAP 003-2023 Guidelines for application of space separative closed systems for cell therapies production
  • T/SHPPA 019-2023 Guidance for the manufacturing quality management of plasmids used in the production of Immune cell therapy products
  • T/GDC 262-2023 Tissue Culture Plate Insert
  • T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products
  • T/CECCEDA 003.1-2023 Technical requirement of single-use materials in CAR-T production Part 1: Cell frozen bag、Cell storage bag
  • T/CACM 1481-2023 Technical regulation of medicinal plant cell culture
  • T/CMBA 021-2023 Specification of quality management for ancillary materials present during the production of cellular therapeutic products
  • T/CGCPU 010-2020 Environmental requirements for the preparation of immune cell products
  • T/GDC 263-2023 Cell and tissue culture dish
  • T/CRHA 014-2022 Specification for menstrual blood-derived mesenchymal stem cells resource storage - Part 3:Quality evaluation and release of menstrual blood-derived mesenchymal stem cells products
  • T/CEAC 039-2024 Stem cell identification methods
  • T/SRA 003-2020 Preparation and Quality Control of Embryonic Stem Cell derived Marrow Mesenchymal Stem Cell
  • T/CSCB 0002-2022 Human Natural Killer Cells
  • T/GDC 207-2023 Cell and Tissue Culture Plates
  • T/SDHCST 002-2023 Test Substance Requirements on the Non-Clinical Studies of the Cell Therapy Medical Products
  • T/GDC 166-2022 Cell culture flask
  • T/SHPPA 021-2023 Import and export management guidance for CAR-T cell therapy products and their materials
  • T/CSSCR 002-2019 Human embryonic stem cell
  • T/LNSI 009-2024 Human natural killer cells
  • T/SRA 001-2019 Standards for establishment of seed cell bank of human adipose-derived mesenchymal stem cells
  • T/SHSYCXH 7-2022 Test method of human monocyte populations from peripheral blood-Flow cytometry
  • T/CSTE 0379-2023 Identification and Cytoactivity Determination of Bioactive Peptides
  • T/CGCPU 019-2022 Material management requirements for immune cell product donors
  • T/CSCB 0007-2021 Human cardiomyocyte
  • T/GDC 206-2023 Roller bottles for issue culture
  • T/CSCB 0004-2022 Human neural stem cell
  • T/LNSI 004-2024 Human cytokine induced killer cell
  • T/CSCB 0002-2020 Human embryonic stem cell
  • T/SDHCST 007-2023 Procedures for Repeated Dose Toxicity Testing of the Cell Therapy Medical Products
  • T/CIET 416-2024 Stem cell anti-aging product development guide
  • T/GDC 167-2022 Multi-Layer cell culture system
  • T/CSCB 0001-2020 General requirements for stem cells
  • T/CSCB 0007-2022 General requirements for production of extracellular vesicles derived from human stem cells
  • T/GDC 212-2023 Cell Scrapers/Flat Blade Cell Lifter
  • T/GDCA 023-2023 Cosmetic ingredients- Bifida ferment lysate
  • T/ZSA 150-2023 Management requirements for donor materials of immune cell product
  • T/SDHCST 005-2023 Procedures for Safety Pharmacology Testing of the Cell Therapy Medical Products
  • T/CECCEDA 002-2023 Manufacture practice of single-use materials in CAR-T production
  • T/SDHCST 004-2023 Animal Species and Model Selection for Non-clinical Studies of the Cell Therapy Medical Products

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB/T 42466-2023 Biobanking technical requirement for management of pluripotent stem cells
  • GB 15193.5-2003 Bone marrow cell micronucleus test
  • GB/T 21793-2008 Chemicals - Test method of in vitro mammalian cell gene mutation
  • GB/T 42076.1-2022 Biotechnology—Cell counting—Part 1: General guidance on cell counting methods
  • GB/T 38506-2020(英文版) Determination of biochemical parameters in animal cell culture process
  • GB/T 15670.17-2017 Toxicological test methods for pesticides registration. Part 17: Mammalian spermatogonial/spermatocyte chromosome aberration test
  • GB 15193.6-2003 Mammalian bone marrow cell chromosome aberration test

Professional Standard - Chemical Industry

国家市场监督管理总局、中国国家标准化管理委员会

  • GB/T 38484-2020 Determination of the biological activity for plant hormone-related secondary metabolites. Cytological method
  • GB/T 40365-2021 General guide for cell sterility testing
  • GB/T 39730-2020 General requirements for cell counting—Flow cytometry
  • GB/T 39729-2020 General requirements for measurement of cell purity—Flow cytometry

Professional Standard - Hygiene

  • WS/T 245-2005 Reference method for the enumeration of erythrocytes and leucocytes
  • WS/T 123-1999 Determination of hematocrit
  • WS/T 360-2024 Guideline for enumeration of peripheral blood lymphocyte subsets by flow cytometry
  • WS/T 360-2011 Guidelines for peripheral lymphocyte subsets by flow cytometry

Professional Standard - Medicine

海关总署

  • SN/T 5159-2019 Chemicals-Transgenic rodent somatic and germ cell gene mutation assays

农业农村部

Professional Standard - Aquaculture

Professional Standard - Machinery

  • JB/T 20137-2011 Mechanical stirred-tank bioreactor for animal cell cultivation

Guangdong Provincial Standard of the People's Republic of China

  • DB4403/T 121-2020 Transportation technology and management regulations of human cell products

National Health Commission of the People's Republic of China

  • WST 360:2011 Guidelines for detection of peripheral blood lymphocyte subsets by flow cytometry

国家食品药品监督管理局

  • YY/T 1562-2017 Tissue engineering medical device products-Biomaterial scaffolds-Guide for cell viability evaluation

Professional Standard - Commodity Inspection

  • SN/T 2179-2008 Mammalian spermatogonial chromosome aberration test
  • SN/T 2178-2008 Test method of in vivo mammalian erythrocyte micronucleus for dangerous goods

Professional Standard - Pharmaceutical Packaging

国家药监局

  • YY/T 1465.6-2019 Immunogenic evaluation method of medical devices―Part 6:Determination of animal spleen lymphocyte subsets by flow cytometry

Association Francaise de Normalisation

  • NF S91-145:1988 Dentistry. Dental implants. Cytocompatibility. Study of cells attachment and spreading on the biomaterial.
  • NF S91-142:1988 Dental implants. Cytocompatibility. Study of cellular proliferation.
  • NF S91-143:1988 Dental implants. Cytocompatibility. Study of total cellular proteins.
  • NF S91-144:1988 Dental implants. Cytocompatibility. Evaluation of 51CR extracellular release.
  • NF EN 16418:2014 Paper and cardboard - Determination of the cytotoxic effect of aqueous extracts using a hepatoma cell line possessing metabolic enzymes (HepG2 cells)
  • NF S91-146:1988 Dental implants. Cytocompatibility. Study of cellular multiplication, migration and adherence.
  • NF X42-003:1988 Biotechnologies - Vocabulaire - Plantes transgéniques et cultures cellulaires.
  • NF EN 12885:1999 Biotechnology - Performance criteria for cell crushers
  • NF Q03-111*NF EN 16418:2014 Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • NF EN 15845:2010 Paper and cardboard - Determination of the cytotoxicity of aqueous extracts
  • NF V18-111:1998 Animal feeding stuffs. Determination of water-insoluble vegetable cell walls content
  • NF Q03-098*NF EN 15845:2010 Paper and board - Determination of the cytotoxicity of aqueous extracts
  • NF X42-141*NF EN 12885:1999 Biotechnology. Performance criteria for cell disrupters.
  • NF U47-200:2004 Animal health analysis methods - Good practice guide for cell cultures.

US-FCR

British Standards Institution (BSI)

  • BS ISO 20391-1:2018 Biotechnology. Cell counting. General guidance on cell counting methods
  • BS ISO 24479:2024 Biotechnology. Cellular morphological analysis. General requirements and considerations for cell morphometry to quantify cell morphological features
  • PAS 157:2015 Evaluation of materials of biological origin used in the production of cell-based medicinal products. Guide
  • 23/30466937 DC BS ISO 24479 Biotechnology — Cellular morphological analysis — General requirements and considerations for cell morphometry to quantify cell morphological features
  • 23/30463781 DC BS ISO 18162. Biotechnology. Biobanking. Requirements for human neural stem cells derived from pluripotent stem cells
  • BS PAS 157:2015 Evaluation of materials of biological origin used in the production of cell-based medicinal products. Guide
  • BS ISO 18362:2016+A1:2022 Manufacture of cell-based health care products. Control of microbial risks during processing
  • BS ISO 20399:2022 Biotechnology. Ancillary materials present during the production of cellular therapeutic products and gene therapy products
  • BS EN 12885:1999 Biotechnology - Performance criteria for cell disrupters
  • BS EN 16418:2014 Paper and board. Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • 22/30424231 DC BS ISO 20399. Biotechnology. Ancillary materials present during the production of cellular therapeutic products and gene therapy products
  • BS EN ISO 17174:2024 Molecular biomarker analysis. DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments
  • 23/30484463 DC BS EN ISO 17174 Molecular biomarker analysis. DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments
  • 24/30469263 DC BS ISO 8472-2 Biotechnology. Data interoperability for stem cell data - Part 2: Key characteristics of stem cell data
  • BS EN 15845:2010 Paper and board - Determination of the cytotoxicity of aqueous extracts
  • 23/30468623 DC BS EN ISO 17174. Molecular biomarker analysis. DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments
  • BS EN ISO 3040:2016 Geometrical product specifications (GPS). Dimensioning and tolerancing. Cones

HU-MSZT

  • MSZ 11645-1970 Medicinal plant cells (Phaseolus vulgaris)
  • MSZ 5278-1957 Medicinal plant tart cherry. Cherry Embryonic Stem Cells (Cerasi)

Standard Association of Australia (SAA)

American National Standards Institute (ANSI)

  • ADA TR 1089-2019 Track and Trace for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
  • ADA TR 1089-2016 Track and Trace for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
  • ANSI/NCCLS H7-A 2-1996 Procedure for Determining Packed Cell Volume by the Microhematocrit Method

American Society for Testing and Materials (ASTM)

  • ASTM F3368-19 Standard Guide for Cell Potency Assays for Cell Therapy and Tissue Engineered Products
  • ASTM F3354-19 Standard Guide for Evaluating Extracellular Matrix Decellularization Processes
  • ASTM D3576-20 Standard Test Method for Cell Size of Rigid Cellular Plastics
  • ASTM E2526-22 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
  • ASTM E2526-08(2013) Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
  • ASTM E2526-08 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
  • ASTM D6226-21 Standard Test Method for Open Cell Content of Rigid Cellular Plastics
  • ASTM F895-84(2001)e1 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM F895-84(2006) Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM E2643-09 Standard Terminology Relating to Natural Multi-Cellular Biological Control Organisms
  • ASTM F895-84(2001) Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM F895-11(2016) Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
  • ASTM E2643-08 Standard Terminology Relating to Natural Multi-Cellular Biological Control Organisms

SCC

  • AWWA ACE63225 Mammalian Cell Toxicity of Emerging Drinking Water Disinfection Byproducts
  • DANSK DS/ISO 20391-1:2018 Biotechnology – Cell counting – Part 1: General guidance on cell counting methods
  • ADA 1089-2016 Track and Trace for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Technical Report
  • DANSK DS/ISO 20399:2022 Biotechnology – Ancillary materials present during the production of cellular therapeutic products and gene therapy products
  • AWWA WQTC71345 The Influence of Bacterial Extracellular Polymeric Substances on the Inactivation Kinetics of Bacteria
  • BS PD ISO/TS 20399-1:2018 Biotechnology. Ancillary materials present during the production of cellular therapeutic products-General requirements
  • BS 2554:1954 Sedimentation tubes for red blood corpuscles
  • DANSK DS/EN 12885:1999 Biotechnology - Performance criteria for cell disrupters
  • DANSK DS/EN 16418:2014 Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • NS-EN 16418:2014 Paper and board — Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • NS-EN 12885:1999 Biotechnology — Performance criteria for cell disrupters
  • DANSK DS/EN 15845:2010 Paper and board - Determination of the cytotoxicity of aqueous extracts
  • NS-EN 15845:2010 Paper and board — Determination of the cytotoxicity of aqueous extracts
  • HOLDEN HN 0082-2012 Cell Count in Expanded Vinyl Coated Fabrics
  • DIN EN 16418 E:2012 Draft Document - Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2); German version prEN 16418:2012
  • HOLDEN HN 0082-1971 Cell Count in Expanded Vinyl Coated Fabrics
  • DANSK DS/CEN/TS 17710:2022 Plant biostimulants – Detection of Listeria monocytogenes
  • AWWA JAW46220 Journal AWWA — Using Flow Cytometry to Detect Protozoa
  • 12/30259424 DC BS EN 16418. Paper and board. Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • AAMI BF64:2012 Leukocyte reduction filters
  • SN-CEN/TS 17710:2022 Plant biostimulants - Detection of Listeria monocytogenes
  • BS ISO 3040:2009 Geometrical product specifications (GPS). Dimensioning and tolerancing. Cones
  • DANSK DS/ISO/TS 20399-1:2018 Biotechnology – Ancillary materials present during the production of cellular therapeutic products – Part 1: General requirements

GOST

International Organization for Standardization (ISO)

  • ISO 20391-1:2018 Biotechnology - Cell counting - Part 1: General guidance on cell counting methods
  • ISO/DIS 24479:2023 Biotechnology — Cellular morphological analysis — General requirements and considerations for cell morphometry to quantify cell morphological features
  • ISO 4898:2018 Rigid cellular plastics — Thermal insulation products for buildings — Specifications
  • ISO 20399:2022 Biotechnology — Ancillary materials present during the production of cellular therapeutic products and gene therapy products
  • ISO/TS 20399-1:2018 Biotechnology — Ancillary materials present during the production of cellular therapeutic products — Part 1: General requirements
  • ISO/FDIS 17174:2024 Molecular biomarker analysis-DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments
  • ISO 17174:2024 Molecular biomarker analysis — DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments
  • ISO/DIS 17174 Molecular biomarker analysis — DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments
  • ISO 21973:2020 Biotechnology — General requirements for transportation of cells for therapeutic use

KR-KS

  • KS M ISO 4590-2018 Rigid cellular plastics — Determination of the volume percentage of open cells and of closed cells
  • KS J ISO 20391-1-2019 Biotechnology — Cell counting — Part 1: General guidance on cell counting methods
  • KS M ISO 4898-2018 Rigid cellular plastics — Thermal insulation products for buildings — Specifications
  • KS P 1600-2018(2023) General guideline of safety test for the cell based therapeutic substances
  • KS J ISO 21973-2023 Biotechnology — General requirements for transportation of cells for therapeutic use

IT-UNI

  • UNI ISO 20391-1:2021 Biotechnology - Cell counting - Part 1: General guidance on cell counting methods
  • UNI ISO 21973:2021 Biotechnology - General requirements for transportation of cells for therapeutic use

Korean Agency for Technology and Standards (KATS)

CZ-CSN

United States Navy

German Institute for Standardization

  • DIN EN ISO 18362:2018-11 Manufacture of cell-based health care products - Control of microbial risks during processing (ISO 18362:2016); German and English version prEN ISO 18362:2018 / Note: Date of issue 2018-09-28
  • DIN EN 12885:1999-04 Biotechnology - Performance criteria for cell disrupters; German version EN 12885:1999
  • DIN 58932-2:1998 Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)
  • DIN 58932-2:1998-06 Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)
  • DIN EN 16418:2014-07 Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2); German version EN 16418:2014
  • DIN EN ISO 17174:2023-06 Molecular biomarker analysis - DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments (ISO/DIS 17174:2023); German and English version prEN ISO 17174:2023 / Note: Date of issue 2023-05-...
  • DIN EN 15845:2010-05 Paper and board - Determination of the cytotoxicity of aqueous extracts; German version EN 15845:2010
  • DIN EN 16418 E:2012-04 Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • DIN EN ISO 17174:2024 Molecular biomarker analysis - DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments (ISO/DIS 17174:2023); German and English version prEN ISO 17174:2023
  • DIN EN ISO 17174:2024-03 Molecular biomarker analysis - DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments (ISO/DIS 17174:2023); German and English version prEN ISO 17174:2023 / Note: Date of issue 2024-01-...
  • DIN 12980:2005 Laboratory furniture - Safety cabinets for handling cytotoxic substances

European Committee for Standardization (CEN)

  • EN 12885:1999 Biotechnology - Performance criteria for cell disrupters
  • EN 16418:2014 Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • EN 15845:2010 Paper and board - Determination of the cytotoxicity of aqueous extracts
  • prEN ISO 17174 Molecular biomarker analysis - DNA barcoding of fish and fish products using defined mitochondrial cytochrome b and cytochrome c oxidase I gene segments (ISO/DIS 17174:2023)

Spanish Association for Standardization (UNE)

  • UNE-EN 16418:2014 Paper and board - Determination of the cytotoxicity of aqueous extracts using a metabolically competent hepatoma cell line (HepG2)
  • UNE-EN 12885:1999 Biotechnology - Performance criteria for cell disrupters
  • UNE-EN 15845:2010 Paper and board - Determination of the cytotoxicity of aqueous extracts

Lithuanian Standards Office

Danish Standards Foundation

  • DS/EN 12885:1999 Biotechnology - Performance criteria for cell disrupters
  • DS/EN 15845:2010 Paper and board - Determination of the cytotoxicity of aqueous extracts

CU-NC

  • NC 74-44-1986 Cattle-Raising. Animal Feeding Determination of Cellulolitic Moss and Flora

UNKNOWN

GOSTR

  • GOST 34660-2020 Methods of testing the impact of chemical products on the human body. Micronucleus analysis on the erythrocytes of mammals

PL-PKN

  • PN A75052-10-1990 Fruits, vegetables and vegetable meat products Methods of microbiological analyses Enumeration and determination of titre of anaerobic sporeforming bacterias, mesophilic and thermophilic
  • PN BN 6052-01-1963 Pesticides. Lepidoplasma fungi organic matter results biomarkers

US-CFR-file

  • CFR 9-113.304-2014 Animals and animal products. Part113:Standard requirements. Section113.304:Feline Panleukopenia Vaccine.

IPC - Association Connecting Electronics Industries

GSO

  • GSO ASTM F3206:2022 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
  • BH GSO ASTM F3206:2023 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies

Canadian Standards Association (CSA)